Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Overview of attention for article published in New England Journal of Medicine, September 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 71 news outlets
blogs: 7 blogs
twitter: 554 X users
facebook: 4 Facebook pages
wikipedia: 1 Wikipedia page

reddit: 4 Redditors
video: 6 YouTube creators
guideline: 7 clinical guideline sources
bluesky: 12 Bluesky users
podcasts: 13 podcasts

Readers on

mendeley: 567 Mendeley

So far, Altmetric has seen 5 public wall posts from 4 users.

Centre for Evidence-based Medicine, 09 Jun 2025

https://www.nejm.org/doi/full/10.1056/NEJMoa2407107?query=cardiology

The New England Journal of Medicine, 20 Feb 2025

NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the FINEARTS-HF trial examining the efficacy and safety of…

The New England Journal of Medicine, 08 Jan 2025

𝐍𝐨𝐭𝐚𝐛𝐥𝐞 𝐀𝐫𝐭𝐢𝐜𝐥𝐞𝐬 𝐨𝐟 𝟐𝟎𝟐𝟒 In the FINEARTS-HF trial, finerenone resulted in a lower rate of total worsening heart failure…

Sociedade Portuguesa de Cardiologia, 10 Dec 2024

“Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction” é o artigo destacado pelo Grupo de Estudo de…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 1 additional Facebook posts.